March 26, 2021
Latham & Watkins LLP advised Siemens
Healthineers AG (Siemens Healthineers) on a further capital increase with gross
proceeds of around €2.34 billion. The 53 million new shares were placed with
institutional investors through an accelerated bookbuilding offering at a price
of €44.10 per share without a prospectus. The capital increase was carried out
utilizing in part the existing authorized capital and excluding the
subscription rights of shareholders.
Siemens Healthineers’ share capital will thereby increase to €1.128 billion. Admission of the new shares for trading in the
sub-segment of the regulated market with additional post-admission obligations
(Prime Standard) of the Frankfurt Stock Exchange is expected to take place on
March 26, 2021.
With the net proceeds from the capital
increase, Siemens Healthineers will complete the equity-related part of the
Latham & Watkins previously advised Siemens
Healthineers on the acquisition of Varian, as well as on the first share
placement for the acquisition financing in September 2020.
Latham represented Siemens
Healthineers with a team led by Frankfurt partner Oliver Seiler, with partner David Rath and associate Camilla Kehler-Weiß.